ARS Pharmaceuticals SPRY
NASDAQ SPRY
$4.28 -0.12 (-2.61%)
As of: Sep 30, 2026 · 1:30 PM EDT

ARS Pharmaceuticals, Inc. (SPRY) Net Cash Flow (2020 - 2026)

Updated

ARS Pharmaceuticals (SPRY) recorded Net Cash Flow of -$16.16 million in Q2 2026, compared with $11.68 million a year earlier.

Analysis

ARS Pharmaceuticals, Inc. (SPRY) Net Cash Flow (2020 - 2026) Analysis & Trends

On a TTM basis, ARS Pharmaceuticals' Net Cash Flow came in at -$43.38 million as of Jun 30, 2026; for FY2025, it was -$9.5 million.

  • Across earlier years, Net Cash Flow came in at -$20.15 million in FY2024, -$139.55 million in FY2023, $150.46 million in FY2022 (+323.3%) and $35.54 million in FY2021 (-90.6%).
  • Quarterly Net Cash Flow has ranged from -$122.66 million in Q1 2023 to $173.2 million in Q4 2022 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$17 million (Q1 2026), -$18.24 million (Q4 2025) and $8.02 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -16.16 Mn
Mar 31, 2026 -17.00 Mn
Dec 31, 2025 -18.24 Mn
Sep 30, 2025 8.02 Mn
Jun 30, 2025 11.68 Mn
Mar 31, 2025 -10.95 Mn
Dec 31, 2024 11.16 Mn
Sep 30, 2024 3.03 Mn
Jun 30, 2024 -19.38 Mn
Mar 31, 2024 -14.97 Mn
Dec 31, 2023 10.44 Mn
Sep 30, 2023 -58.49 Mn
Jun 30, 2023 31.16 Mn
Mar 31, 2023 -122.66 Mn
Dec 31, 2022 173.20 Mn
Sep 30, 2022 -7.27 Mn
Jun 30, 2022 -7.62 Mn
Mar 31, 2022 -7.85 Mn
Dec 31, 2021 121.45 Mn
Sep 30, 2021 -59.03 Mn
API Access

ARS Pharmaceuticals, Inc. Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=SPRY&period=max&api_key=YOUR_API_KEY